Cargando…
Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887311/ https://www.ncbi.nlm.nih.gov/pubmed/24300975 http://dx.doi.org/10.1038/bjc.2013.737 |
| _version_ | 1782479003240628224 |
|---|---|
| author | Omlin, A Pezaro, C J Zaidi, S Lorente, D Mukherji, D Bianchini, D Ferraldeschi, R Sandhu, S Dearnaley, D Parker, C Van As, N de Bono, J S Attard, G |
| author_facet | Omlin, A Pezaro, C J Zaidi, S Lorente, D Mukherji, D Bianchini, D Ferraldeschi, R Sandhu, S Dearnaley, D Parker, C Van As, N de Bono, J S Attard, G |
| author_sort | Omlin, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3887311 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38873112014-01-10 Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' Omlin, A Pezaro, C J Zaidi, S Lorente, D Mukherji, D Bianchini, D Ferraldeschi, R Sandhu, S Dearnaley, D Parker, C Van As, N de Bono, J S Attard, G Br J Cancer Letter to the Editor Nature Publishing Group 2014-01-07 2013-12-03 /pmc/articles/PMC3887311/ /pubmed/24300975 http://dx.doi.org/10.1038/bjc.2013.737 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Letter to the Editor Omlin, A Pezaro, C J Zaidi, S Lorente, D Mukherji, D Bianchini, D Ferraldeschi, R Sandhu, S Dearnaley, D Parker, C Van As, N de Bono, J S Attard, G Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title | Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_full | Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_fullStr | Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_full_unstemmed | Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_short | Reply: ‘Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_sort | reply: ‘comment on anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887311/ https://www.ncbi.nlm.nih.gov/pubmed/24300975 http://dx.doi.org/10.1038/bjc.2013.737 |
| work_keys_str_mv | AT omlina replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT pezarocj replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT zaidis replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT lorented replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT mukherjid replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT bianchinid replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT ferraldeschir replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT sandhus replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT dearnaleyd replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT parkerc replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT vanasn replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT debonojs replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT attardg replycommentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer |